Garth Ringheim

Person

Belle Mead, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating vitiligo using PD-1 binding antibodies
- Patent number 10,766,958
- Issue date Sep 8, 2020
- Celgene Corporation
- Garth E. Ringheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating psoriasis using PD-1 binding antibodies
- Patent number 10,751,414
- Issue date Aug 25, 2020
- Celgene Corporation
- Henry H. Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,741,493
- Issue date Jun 22, 2010
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,326,792
- Issue date Feb 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING VITILIGO USING PD-1 BINDING ANTIBODIES
- Publication number 20210163595
- Publication date Jun 3, 2021
- Celgene Corporation
- Garth E. RINGHEIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
- Publication number 20210069325
- Publication date Mar 11, 2021
- Celgene Corporation
- Henry H. CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
- Publication number 20180092975
- Publication date Apr 5, 2018
- Celgene Corporation
- Henry H. CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING VITILIGO USING PD-1 BINDING PROTEINS
- Publication number 20180094057
- Publication date Apr 5, 2018
- Celgene Corporation
- Garth E. RINGHEIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
- Publication number 20170173011
- Publication date Jun 22, 2017
- CELGENE AVILOMICS RESEARCH, INC.
- William Frederick Westlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS
- Publication number 20080132550
- Publication date Jun 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick SHUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic compounds as P2X7 ion channel blockers
- Publication number 20050026916
- Publication date Feb 3, 2005
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY

Garth Ringheim

Person

Patents Grantslast 30 patents

Methods of treating vitiligo using PD-1 binding antibodies

Methods of treating psoriasis using PD-1 binding antibodies

Heterocyclic compounds as P2X7 ion channel blockers

Heterocyclic compounds as P2X7 ion channel blockers

Patents Applicationslast 30 patents

METHODS OF TREATING VITILIGO USING PD-1 BINDING ANTIBODIES

METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS

METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS

METHODS OF TREATING VITILIGO USING PD-1 BINDING PROTEINS

METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER

HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS

Heterocyclic compounds as P2X7 ion channel blockers